ЭФФЕКТ ПЛАЦЕБО И ЭПИЛЕПСИЯ

1. Perkins B.D. The Influence of Metallic Tractors on the Human Body, in removing various painful inflammatory diseases, such as rheumatism, pleurisy, some gouty affections, &c. &c.: Lately discovered by Dr. Perkins, of North America, and demonstrated in a series of experiments and observations, by professors Meigs, Woodward, Rogers, &c. &c.: by which the importance of the discovery is fully ascertained, and a new field of enquiry opened in the modern science of galvanism, or, animal electricity. 1798; Printed for J. Johnson and Ogilvy and Son, London; Reprint: ECCO (Eighteenth Century Collections Online) Print Editions 2011, LaVergne, Tennessee.

2. Haygarth J. Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the literary and philosophical society of bath. 1800; Bath, Cruttwell; Reprint: ECCO [Eighteenth Century Collections Online] Print Editions 2011, LaVergne, Tennessee.

3. https://www.placeboeffect.com.

4. Shapiro A. The placebo effect. In: Principles of Psychopharmacology. N.Y. 1978; 441-459.

5. Лапин И.П. Плацебо и терапия. Спб. 2000; 8-12, 46-49.

6. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb; 15; 90 (3): 205-15.

7. Haltia L.T., Rinne J.O., Helin S., Parkkola R., Nagren K., Kaasinen V. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse. 2008; 62 (9): 682-8.

8. Petrovic P., Kalso E., Petersson K.M., Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science. 2002 Mar 1; 295 (5560): 1737-40.

9. Murray D., Stoessl A.J. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions, Pharmacol. Ther. 2013 Dec; 140 (3): 306-18.

10. Marson A.G., Kadir Z.A., Chadwick D.W. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 1996 Nov 9; 313 (7066): 1169-74.

11. Burneo J.G., Montori V.M., Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav. 2002; 3: 532-4.

12. Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia. 2010; 51: 7-26.

13. Guekht A.B., Korczyn A.D., Bondareva I.B., Gusev E.I. Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav. 2010; 17: 64-9.

14. Rheims S., Cucherat M., Arzimanoglou A., Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008 Aug 12; 5 (8): e166.

15. Tachibana Y., Narukawa M. Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis. Clin Drug Investig. 2013 May; 33(5): 315-24.

16. Pollo A., Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009; 175: 283-94.

17. Thomas K.B. General practice consultations: is there any point in being positive? Br Med J. 1987; 294: 1200-1202.

18. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb15; 90 (3): 205-15.

19. Branthwaite A., Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed). 1981 May 16; 282 (6276): 1576-8.

20. Schmidt D., Beyenburg S., DSouza J., Stavem K. Clinical features associated with placebo response in refractory focal epilepsy. Epilepsy Behav. 2013; 27: 393-398.

21. French J., Brandt C., Friedman D., Biton V., Knapp L., Pitman V., Chew M., Dubrava S., Posner H.B. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial. Epilepsia. 2014 Jun 24. doi: 10.1111/epi.12690. [Epub ahead of print].

22. Arnold L.M., Arsenault P., Huffman C., Patrick J.L., Messig M., Chew M.L., Sanin L., Scavone J.M., Pauer L., Clair A.G. Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a Phase III, double-blind, randomized withdrawal, placebo-controlled study. Curr Med Res Opin. 2014 May 27; 1-35.

23. http://www.clinicaltrials.gov/ct2/results?term=pregabalin+CR&Search=Search.